-
1 Comment
STAAR Surgical Company is currently in a long term uptrend where the price is trading 44.2% above its 200 day moving average.
From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 30.9.
STAAR Surgical Company's total revenue rose by 18.3% to $46M since the same quarter in the previous year.
Its net income has dropped by 47.8% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 155.4% to $17M since the same quarter in the previous year.
Based on the above factors, STAAR Surgical Company gets an overall score of 4/5.
Industry | Medical Instruments & Supplies |
---|---|
Exchange | F |
CurrencyCode | EUR |
ISIN | US8523123052 |
Sector | Healthcare |
Market Cap | 753M |
---|---|
PE Ratio | None |
Target Price | 147 |
Beta | 0.75 |
Dividend Yield | None |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SR3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025